Category: Health News

Study Links Lockdown Policies and Mask Mandates With Lower IQ in Children

The nation’s recent lockdown policies and mask mandates will create a generation of children who exhibit lower IQs and signs of social brain damage, according to a clinical psychiatrist for children and adolescents. Dr. Mark McDonald cited an Aug. 11 study by Brown University (pdf) that found that “children born during the pandemic have significantly…


Lockdown Policies and Mask Mandates Linked With Lower IQ in Children: Psychiatrist

The nation’s recent lockdown policies and mask mandates will create a generation of children who exhibit lower IQs and signs of social brain damage, according to a clinical psychiatrist for children and adolescents. Dr. Mark McDonald cited an Aug. 11 study by Brown University (pdf) that found that “children born during the pandemic have significantly…


Outpatient Treatments for COVID-19 Reviewed

Dr. Pierre Kory is one of the leaders in the movement to provide early treatment for COVID infection. Kory is a critical care physician (ICU specialist), triple board certified in internal medicine, critical care and pulmonary medicine, and is part of the Frontline COVID-19 Critical Care Alliance (FLCCC), which was among the first to publish…


Roche Says At-home COVID-19 Rapid Test Gets Ok From FDA

Roche said on Friday that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to its COVID-19 at-home rapid test that can be used by people as young as 14. The test, which uses an anterior nasal swab sample, is “able to produce accurate, reliable and quick results in as few…


No Supply Issues With Ivermectin: Pharmaceutical Supplying PRINCIPLE Oxford Trial

The New Jersey pharmaceutical company supplying ivermectin to a UK trial that was paused for a short period of time, says there are no supply issues with its pills. Ivermectin is being investigated as part of the government-backed Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) in the United…


Biogen, Eisai Alzheimer’s Drug Lecanemab Gets ‘Fast Track’ Designation From FDA

Biogen Inc. and Japanese partner Eisai Co. said on Thursday the U.S. Food and Drug Administration (FDA) had granted “fast track” designation to their experimental therapy lecanemab for the treatment of early Alzheimer’s disease. The FDA had granted “breakthrough” therapy designation to the drug earlier this year. The drug works in a similar manner to…


NIH: Check Out Wikipedia to See Why Great Barrington Declaration is ‘Dangerous’

The National Institutes of Health (NIH) and its top officials are doubling down on criticism of the Great Barrington Declaration after emails showed they quickly moved last year to oppose it. The declaration, penned last year, said lockdowns were producing negative short- and long-term effects on public health, such as lower childhood vaccination rates, fewer…


This Disease Has Soared 28x Since the 1960s, but Why?

In the mid-1960s, the autism rate was 1 in 10,000. By 2012, it had risen to 1 in 88, then 1 in 68 as of 2016, and now, we’re looking at an autism rate of 1 in 44 8-year-olds, although rates vary widely from state to state.4 In California, where incidence is the highest, 1 in 26 8-year-olds…


CDC, FDA Investigating Listeria Outbreaks in Recalled Packaged Salads

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) both confirmed they are investigating two separate Listeria bacteria outbreaks linked to packaged salads. Two companies, Dole Fresh Vegetables and Fresh Express, voluntarily recalled packaged salad products in connection to the Listeria monocytogenes contamination. The CDC said that at least three deaths have…


FDA Authorizes Merck’s COVID-19 Pill Weeks After US Makes $2.2 Billion Purchase

The Food and Drug Administration (FDA) on Thursday morning issued an emergency use authorization for Merck’s antiviral pill for COVID-19, more than 12 hours after giving the green light for a similar, oral drug made by Pfizer. Merck’s drug, named molnupiravir, was developed with Ridgeback Biotherapeutics, and it was shown to reduce hospitalizations and deaths from…